Lapinig, Garmie B.

HRN: 22-07-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2022
AMPICILLIN 1GM (VIAL)
10/15/2022
10/21/2022
IVTT
2gms
Q6H
PROM
Waiting Final Action 
10/16/2022
CEFUROXIME 1.5GM (VIAL)
10/16/2022
10/22/2022
IV
1.5 G
Now The Q8
Second Degree Laceration, Thickly Msaf
Waiting Final Action 
10/16/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/16/2022
10/22/2022
IV
500mg
Q8
Second Degree Laceration, Thickly Msaf
Waiting Final Action 
10/16/2022
CEFUROXIME 500MG (TAB)
10/16/2022
10/23/2022
PO
500mg
Q12
S/P LTCS
Waiting Final Action 
10/16/2022
METRONIDAZOLE 500MG (TAB)
10/16/2022
10/23/2022
PO
500mg
Q12
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: